2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with alosetron in 1 studies
Studies (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Trials (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Recent Studies (post-2010) (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Studies (alosetron) | Trials (alosetron) | Recent Studies (post-2010) (alosetron) |
---|---|---|---|---|---|
135 | 6 | 50 | 226 | 37 | 33 |
Protein | Taxonomy | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (IC50) | alosetron (IC50) |
---|---|---|---|
Cytochrome P450 1A2 | Homo sapiens (human) | 5.3024 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.6 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 10 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 10 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 10 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.1 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.068 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and alosetron
Article | Year |
---|---|
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |